Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing.
The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 to $26 apiece, for a total range of $256.8 million to $278.2 million (its initial filing earlier this month was for a $100 million raise).
Get the full story at our sister site, Drug Delivery Business News